Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 1/20 | 0.71 |
| ▸ | NPC1 | O15118 | 9/20 | 0.62 |
| ▸ | RAB9A | P51151 | 8/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | CASP1 | P29466 | 1/20 | 0.62 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.62 |
| ▸ | CASP7 | P55210 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27690690 | 0.93 | FLT3 (0.62) | FLT3NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| Benzofuran SCHEMBL2957261 | 0.88 | FLT3 (0.57) | FLT3NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL28751252 | 0.88 | FLT3 (0.57) | FLT3NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL20280743 | 0.87 | FLT3 (0.56) | FLT3NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL6001320 | 0.85 | ALDH1A1 (0.59) | FLT3NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL6272805 | 0.85 | FLT3 (0.67) | FLT3NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL8915455 | 0.83 | FLT3 (0.64) | FLT3NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL244107 | 0.83 | FLT3 (1.00) | FLT3NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL31061078 | 0.83 | FLT3 (1.00) | FLT3NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL3266442 | 0.83 | FLT3 (0.51) | FLT3NPC1RAB9ASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121584000-A | Composite electrolyte, positive electrode plate and all-solid-state battery | 绿能起源科技(江苏)有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-119753874-A | Luminous anchor net material suitable for stress and preparation method thereof | 中煤科工开采研究院有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-114957238-B | 3-hydroxy-pyrrole-2-ketone compound containing 1,3, 4-thiadiazole and synthetic method and application thereof | 南京工业大学 | 2024-02-06 | — | — | CN | claimed |
| CN-117486872-A | Mechanical ball milling synthesis method of aminothiazole compound | 浙江工业大学 | 2024-02-02 | — | — | CN | claimed |
| CN-117304135-A | Synthesis method of 4-substituted-5H-1, 2, 3-dithiazole-5-thione and derivative | 衡阳师范学院 | 2023-12-29 | — | — | CN | claimed |
| CN-114957238-A | 3-hydroxy-pyrrole-2-ketone compound containing 1,3, 4-thiadiazole and synthetic method and application thereof | 南京工业大学 | 2022-08-30 | — | — | CN | claimed |
| US-10920176-B2 | Transparent liquids, in particular fabric treatment agents, comprising perfume and microcapsules with an odor modulator compound | HENKEL AG & CO. KGAA (DE) | 2021-02-16 | — | — | US | claimed |
| CN-110615771-A | Method for directly synthesizing furazan oxide from methyl ketone | 中国科学院青岛生物能源与过程研究所 | 2019-12-27 | — | — | CN | claimed |
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-20050202505-A1 | Method to identify modulators for human 3alpha-hydroxysteroid dehydrogenase | FLOERSHEIM PHILIPP (CH) | 2005-09-15 | — | — | US | claimed |
| EP-1421383-A2 | METHOD TO IDENTIFY MODULATORS FOR HUMAN 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE | Novartis AG (CH) | 2004-05-26 | — | — | EP | claimed |
| WO-2003018830-A2 | METHOD TO IDENTIFY MODULATORS FOR HUMAN 3α-HYDROXYSTEROID DEHYDROGENASE | NOVARTIS AG (CH) | 2003-03-06 | — | — | WO | claimed |
| EP-0703910-B1 | BENZOYLBENZOFURANE DERIVATIVES FOR TREATMENT OF CARDIAC ARRHYTHMIA | ARYX THERAPEUTICS (US) | 1998-01-07 | — | — | EP | claimed |
| EP-0703910-A1 | BENZOYLBENZOFURANE DERIVATIVES FOR TREATMENT OF CARDIAC ARRHYTHMIA | Advanced Therapies, Inc. (US) | 1996-04-03 | — | — | EP | claimed |
| US-5440054-A | Compound for treatment of cardiac arrhythmia, synthesis, and methods of use | ADVANCED THERAPIES, INC. (US) | 1995-08-08 | — | — | US | claimed |
| WO-1994029289-A1 | BENZOYLBENZOFURANE DERIVATIVES FOR TREATMENT OF CARDIAC ARRHYTHMIA | ADVANCED THERAPIES, INC. (US) | 1994-12-22 | — | — | WO | claimed |
| EP-0156331-B1 | BENZOFURAN DERIVATIVES, PROCESSES FOR PREPARING THE SAME AND ANTIHYPERTENSIVE AGENTS CONTAINING THE SAME | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1989-05-31 | — | — | EP | claimed |
| US-4652566-A | (2-HYDROXY-3-(4-PHENYLPIPERAZINYL)PROPOXY) BENZOFURAN DERIVATIVES; DECREASED SIDE EFFECTS | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1987-03-24 | — | — | US | claimed |
| EP-0156331-A2 | Benzofuran derivatives, processes for preparing the same and antihypertensive agents containing the same | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1985-10-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10920176-B2 | Transparent liquids, in particular fabric treatment agents, comprising perfume and microcapsules with an odor modulator compound | NEFM, TRPA1, ALOX5 | FLT3 3319/4885NPC1 4292/4885RAB9A 4778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.